Adam had it right - From 10-K Sarepta parted with their PRV voucher for $111 million on Valentine's | SRPT Message Board Posts

Sarepta Therapeutics Inc.

  SRPT website

SRPT   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  14068 of 14098  at  2/26/2020 8:21:17 PM  by

pineappleguava


 In response to msg 14067 by  pineappleguava
view thread

Adam had it right - From 10-K Sarepta parted with their PRV voucher for $111 million on Valentine's Day.

"On February 14, 2020, the Company entered into an agreement to sell the rare pediatric disease PRV it received from the FDA in connection with the approval of VYONDYS 53 for consideration of $111.0 million. The closing of the transaction is subject to the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and other customary conditions. When the transaction closes, the net proceeds will be recorded as a gain from sale of the PRV as it does not have a carrying value at the time of the sale."


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 84
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...